Back to Search
RACHEL SEIDMAN, PHARMD
PHARMD
Community/Retail Pharmacy
NPI: 1942776901Individual
Specialties, Licenses & Credentials
Community/Retail PharmacyPrimary
Pharmacy — Community/Retail Pharmacy
Code: 3336C0003X
Research & Publications (10)
Systemic dysregulation of CEACAM1 in melanoma patients.
PMID 19633846·Cancer Immunol Immunother·2010
8-other
Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack.
PMID 18557789·Immunology·2009
8-other
Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.
PMID 19440333·PLoS One·2009
8-other
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma.
PMID 19331144·Anticancer Res·2009
8-other
The keys to successful online continuing education programs for nurses.
PMID 18286929·J Contin Educ Nurs·2008
8-other
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions.
PMID 17056532·J Immunol·2006
7-preclinical
Implementing a seventh grade vaccination law: school factors associated with completion of required immunizations.
PMID 12649060·Prev Med·2003
4-observational
Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent.
PMID 12032672·Cell Death Differ·2002
8-other
The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
PMID 11461121·Exp Cell Res·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 901 BOREN AVE STE 100
SEATTLE, WA 98104 - Phone
- (206) 682-1011
Quick Facts
- NPI
- 1942776901
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile